—
C+
C+ The full Closelook — membership. Open the C+ overview

Laboratorios Farmaceuticos ROVI (ROVI.MC) — Technical state

As of 2026-09-22 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.

Recovery attempt under the 200-day

Trades +1.2% vs the 50-day and -10.5% vs the 200-day average, 30.6% below the 52-week high and +11.8% off the 52-week low; a death cross printed 67 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the ROVI.MC chart & overview · quality & forensics · the signal board

FAQ · from the current data · as of 2026-09-22

Quick answers

What is the current Closelook signal on ROVI.MC?

Recovery attempt under the 200-day — Trades +1.2% vs the 50-day and -10.5% vs the 200-day average, 30.6% below the 52-week high and +11.8% off the 52-week low; a death cross printed 67 sessions ago. Computed from daily closes. As of 2026-09-22; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ROVI.MC above its 50-day and 200-day moving averages?

As of 2026-09-22, Laboratorios Farmaceuticos ROVI trades +1.2% above its 50-day and -10.5% below its 200-day average, with the 20-day +0.2% away.

How far is ROVI.MC from its 52-week high?

30.6% below the 52-week high and 11.8% above the 52-week low, as of 2026-09-22.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.